En esta página
01BCDA precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
BCDA BioCardia, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 12, 2026
$1,04
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$0,75mínimo 52 semanas
$1,80máximo 52 semanas
Capitalización Bursátil (MRQ)
$16M
Ingresos
$0
tus insignias
Rango 52S
$1–$2
Calificación del Analista
BUY
Precio Objetivo
$16
P/E
·
ROE
1660.5%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
BCDA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.04
Capitalización Bursátil (MRQ)
$16M
Ingresos
$0
ROE
1660.5%
Rango 52S
$1–$2
BCDA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 30 de mayo de 2024 | 1-for-15 | Inversa |
| 6 de junio de 2019 | 1-for-9 | Inversa |
| 3 de noviembre de 2017 | 1-for-12 | Inversa |
| 14 de marzo de 2008 | 1-for-10 | Inversa |
| 6 de enero de 2004 | 6-for-1 | Adelante |
| 23 de agosto de 2001 | 1-for-3 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$02016-12-31 → 2025-12-31
Flujo de caja libre$-7M2017-12-31 → 2025-12-31
Margen neto·2017-12-31 → 2024-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | BCDA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/C (MRQ) | 5.8promedio 5A ≈-18.0 | ≈-18.0 | · | · | |
| Precio / FCF (TTM) | -2.1promedio 5A ≈-18.3 | ≈-18.3 | · | · | |
| Precio / Flujo de Caja (TTM) | -2.1promedio 5A ≈-18.5 | ≈-18.5 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 12.5promedio 5A ≈50.7 | ≈50.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | BCDA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -230.6%promedio 5A ≈-178.2% | ≈-178.2% | · | · | |
| ROE | 1660.5%promedio 5A ≈533.6% | ≈533.6% | · | · |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | BCDA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 2.1promedio 5A ≈1.6 | ≈1.6 | 1.3 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 1.0promedio 5A ≈1.5 | ≈1.5 | 1.1 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | BCDA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -87.8%promedio 5A ≈120.2% | ≈120.2% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | -61.5% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | BCDA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.0 | ≈0.0 | · | · | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 0.0promedio 5A ≈2.7 | ≈2.7 | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$0.00 | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
14.5%
Próximo informe
Nov 10, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 12, 2026 | $-0.13 | $-0.18 | 29.2% |
| 31 de marzo de 2026 | May 15, 2026 | $-0.21 | $-0.17 | -24.8% |
| 31 de diciembre de 2025 | $-0.06 | $-0.17 | 65.4% | |
| 30 de septiembre de 2025 | $-0.24 | $-0.23 | -2.3% | |
| 30 de junio de 2025 | $-0.40 | $-0.51 | 21.6% | |
| 31 de marzo de 2025 | $-0.59 | $-0.40 | -48.3% | |
| 31 de diciembre de 2024 | $-0.25 | $-0.64 | 60.8% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $58.0K | $477.0K | $1M | $1M | $145.0K | $710.0K | $625.0K | $479.0K | $576.0K | $904.0K | · | |
| Cost of Revenue | · | · | · | · | $0 | $4.0K | $358.0K | $517.0K | $690.0K | $746.0K | $1M | · | |
| R&D Expense | $5M | $4M | $8M | $9M | $9M | $10M | $9M | $8M | $6M | $3M | $2M | · | |
| SG&A Expense | $3M | $4M | $4M | $4M | $5M | $6M | $6M | $6M | $6M | $4M | $4M | $196.0K | |
| Operating Expenses | $8M | $8M | $12M | $13M | $14M | $16M | $15M | $15M | $13M | $8M | $6M | · | |
| Operating Income | $-8M | $-8M | $-12M | $-12M | $-13M | $-16M | $-14M | $-14M | $-12M | $-8M | $-5M | $231.0K | |
| Interest Expense | · | · | · | · | $0 | $3.0K | $112.0K | · | · | $2M | $1M | · | |
| Interest Income | · | · | · | · | $9.0K | $21.0K | · | · | · | · | · | · | |
| Other Non-op | $50.0K | $55.0K | $73.0K | $-6.0K | $7.0K | $-2.0K | $-2.0K | $-3.0K | $2.0K | $-2.0K | $-2.0K | · | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $322.0K | $234.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-8M | $-12M | $-12M | $-13M | $-15M | $-15M | $-14M | $-12M | $-10M | $-7M | $234.0K | |
| EPS (Basic) | $-1.23 | $-2.90 | $-8.19 | $-0.67 | $-0.75 | · | · | · | · | · | · | · | |
| Shares (Basic) | 6,666,943 | 2,743,828 | 1,411,998 | 17,720,972 | 16,917,664 | · | · | · | · | · | · | · | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | · | · | 230,293,141 | 230,293,141 | |
| EBITDA | $-8M | $-8M | $-12M | · | $-13M | $-15M | $-14M | $-14M | $-12M | · | $319.0K | $231.0K |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $2M | $1M | $7M | $13M | $21M | $6M | $5M | $13M | $21M | $4M | $3M | |
| Receivables | $20.0K | $0 | $63.0K | $201.0K | $147.0K | $232.0K | $147.0K | $274.0K | $95.0K | $74.0K | $107.0K | · | |
| Inventory | · | · | · | · | · | · | $4.0K | $141.0K | $191.0K | $135.0K | $759.0K | · | |
| Prepaid Expense | $216.0K | $251.0K | $295.0K | $300.0K | $462.0K | $401.0K | · | $445.0K | $340.0K | $356.0K | $146.0K | $36.0K | |
| Current Assets | $3M | $3M | $1M | $8M | $13M | $23M | $6M | $6M | $13M | $22M | $5M | · | |
| PP&E (Net) | $16.0K | $33.0K | $94.0K | $170.0K | $182.0K | $145.0K | $181.0K | $145.0K | $169.0K | $111.0K | $150.0K | · | |
| PP&E (Gross) | $801.0K | $794.0K | $788.0K | $789.0K | $719.0K | $1M | $1M | $990.0K | $927.0K | $882.0K | $882.0K | · | |
| Accum. Depreciation | $785.0K | $761.0K | $694.0K | $619.0K | $537.0K | $1M | $957.0K | $845.0K | $758.0K | $771.0K | $732.0K | · | |
| Other Non-current Assets | $171.0K | $171.0K | $171.0K | $171.0K | $172.0K | $54.0K | $54.0K | $54.0K | $54.0K | $54.0K | $43.0K | · | |
| Total Assets | $3M | $4M | $3M | $10M | $16M | $23M | $8M | $6M | $14M | $22M | $5M | $14M | |
| Accounts Payable | $641.0K | $385.0K | $890.0K | $683.0K | $507.0K | $746.0K | $914.0K | $743.0K | $902.0K | $525.0K | $542.0K | $10.0K | |
| Accrued Liabilities | $34.0K | $22.0K | $75.0K | $157.0K | $240.0K | $87.0K | $10.0K | $127.0K | $465.0K | $478.0K | $692.0K | · | |
| Current Liabilities | $2M | $2M | $4M | $4M | $4M | $4M | $4M | $3M | $2M | $1M | $8M | · | |
| Capital Leases | $86.0K | $566.0K | $982.0K | $1M | $2M | $0 | $614.0K | · | · | · | · | · | |
| Total Liabilities | $3M | $3M | $5M | $5M | $5M | $4M | $5M | $3M | $2M | $2M | $8M | $10.0K | |
| Common Stock | $11.0K | $5.0K | $2.0K | $20.0K | $17.0K | $16.0K | $7.0K | $5.0K | $38.0K | $38.0K | $19.0K | $230.0K | |
| Paid-in Capital | $169M | $161M | $151M | $145M | $139M | $135M | $103M | $90M | $84M | $81M | $341.0K | $26M | |
| Retained Earnings | $-168M | $-160M | $-152M | $-141M | $-129M | $-116M | $-101M | $-86M | $-72M | $-60M | $-50M | $-12M | |
| Stockholders' Equity | $895.0K | $837.0K | $-2M | $5M | $10M | $19M | $2M | $4M | $11M | $21M | $-3M | $-43M | |
| Liabilities + Equity | $3M | $4M | $3M | $10M | $16M | $23M | $8M | $6M | $14M | $22M | $5M | $14M | |
| Shares Outstanding | 10,755,647 | 4,600,910 | 1,577,769 | 20,076,773 | 16,871,265 | 16,297,381 | 6,825,183 | 4,845,697 | 38,218,660 | 38,131,303 | 18,947,536 | 230,293,141 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24.0K | $67.0K | $84.0K | $82.0K | $60.0K | $68.0K | $111.0K | $88.0K | $78.0K | $39.0K | $47.0K | · | |
| Stock-based Comp | $430.0K | $741.0K | $1M | $1M | $2M | $3M | $3M | $3M | $3M | $942.0K | $283.0K | $0 | |
| Other Non-cash | $338.0K | $-888.0K | $483.0K | · | $536.0K | $-373.0K | $2M | $56.0K | $852.0K | · | · | · | |
| Operating Cash Flow | $-7M | $-8M | $-10M | $-11M | $-10M | $-12M | $-9M | $-11M | $-9M | $-6M | $-7M | $214.0K | |
| CapEx | $7.0K | $6.0K | $12.0K | $70.0K | $116.0K | $32.0K | $146.0K | $66.0K | $136.0K | · | $125.0K | · | |
| Investing Cash Flow | $-7.0K | $-6.0K | $-12.0K | $-70.0K | $-116.0K | $-32.0K | $-146.0K | $-66.0K | $-136.0K | $19M | $-125.0K | · | |
| Stock Issued | $9M | $11M | $4M | $6M | $2M | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $9M | $11M | $4M | · | $2M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $8M | $9M | $4M | $5M | $2M | $28M | $10M | $4M | $144.0K | $4M | $8M | · | |
| Net Change in Cash | $125.0K | $1M | $-6M | $-6M | $-9M | $16M | $227.0K | · | · | · | $331.0K | $214.0K | |
| Free Cash Flow | $-7M | $-8M | $-10M | · | $-10M | $-12M | $-10M | $-11M | $-9M | · | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -13794.8% | -2441.1% | · | -1244.3% | -10709.7% | -2001.8% | -2256.3% | -2589.8% | · | · | · | |
| Net Margin | · | -13700.0% | -2425.8% | · | -1243.7% | -10347.6% | -2071.7% | -2237.9% | -2569.5% | · | · | · | |
| EBITDA Margin | · | -13679.3% | -2423.5% | · | -1238.4% | -10662.8% | -1986.2% | -2242.2% | -2573.5% | · | · | · | |
| ROA | -230.6% | -236.8% | -181.1% | · | -64.5% | -96.5% | -208.7% | -140.2% | -69.1% | · | 2.3% | 1.7% | |
| ROE | 1660.5% | -442.7% | 1022.6% | · | -106.1% | -128.8% | -388.9% | -415.3% | -77.6% | · | -2.2% | 1.7% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | 2.3% | 1.7% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | 0.4 | · | 3.6 | 5.3 | 1.6 | 2.4 | 5.7 | · | · | · | |
| Quick Ratio | 1.0 | 1.0 | 0.3 | · | 3.5 | 5.1 | 1.4 | 2.2 | 5.5 | · | · | · | |
| Interest Coverage | · | · | · | · | · | -5176.3 | -126.9 | · | · | · | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | · | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | · | · | · | |
| Inventory Turnover | · | · | · | · | · | · | 4.9 | 3.1 | 4.2 | · | · | · | |
| Receivables Turnover | 0.0 | 1.8 | 3.6 | · | 5.4 | 0.8 | 3.4 | 3.4 | 5.7 | · | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.08 | $0.18 | $-0.07 | · | $0.61 | $1.18 | $0.35 | $0.09 | $0.29 | · | $0.06 | $0.06 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | · | $0.00 | $0.00 | |
| Cash / Share | $0.23 | $0.52 | $0.05 | · | $0.76 | $1.31 | $0.82 | $0.12 | $0.33 | · | $0.06 | $0.06 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | -87.8% | -64.7% | 33.2% | 600.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | -61.5% | 48.7% | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $58.0K | $477.0K | $1M | $1M | $145.0K | $710.0K | $625.0K | $479.0K | $576.0K | $904.0K | $47.0K | |
| Net Income TTM | $-8M | $-8M | $-12M | $-12M | $-13M | $-15M | $-15M | $-14M | $-12M | $-10M | $-7M | $234.0K | |
| Market Cap | $13M | $10M | $234M | · | $491M | $846M | $377M | $7.07B | $12.12B | · | $29.85B | $41.04B | |
| P/S | · | 172.9 | 491.2 | · | 483.7 | 5833.3 | 530.6 | 11304.0 | 25312.9 | · | 33015.5 | 873154.0 | |
| P/B | 15.0 | 12.0 | -146.2 | · | 47.3 | 44.1 | 159.0 | 1863.1 | 1089.9 | · | 2152.5 | 3030.0 | |
| P / Tangible Book | 15.0 | 12.0 | · | 128.7 | 47.3 | 44.1 | · | · | · | · | · | · | |
| P / Cash Flow | -1.8 | -1.2 | -23.5 | · | -47.4 | -68.4 | -39.9 | -638.3 | -1398.3 | · | 90169.2 | 191767.5 | |
| P / FCF | -1.8 | -1.2 | -23.5 | · | -46.8 | -68.3 | -39.3 | -634.5 | -1376.7 | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $3.0K | $55.0K | $13.0K | $357.0K | $43.0K | $64.0K | $106.0K | $212.0K | |
| R&D Expense | $893.0K | $1M | $1M | $936.0K | $1M | $2M | $1M | $931.0K | $800.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | |
| SG&A Expense | $730.0K | $1M | $885.0K | $552.0K | $683.0K | $1M | $906.0K | $825.0K | $852.0K | $1M | $941.0K | $1M | $1M | $1M | $924.0K | $1M | |
| Operating Expenses | $2M | $2M | $2M | $1M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $3M | |
| Operating Income | $-2M | $-2M | $-2M | $-1M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-3M | $-3M | |
| Other Non-op | $10.0K | $7.0K | $29.0K | $5.0K | $2.0K | $14.0K | $25.0K | $19.0K | $3.0K | $8.0K | $12.0K | $24.0K | $28.0K | $9.0K | $-10.0K | $3.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-2M | $-2M | $-2M | $-1M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-3M | $-3M | |
| EPS (Basic) | $-0.13 | $-0.21 | $0.00 | $-0.24 | $-0.40 | $-0.59 | $-0.06 | $-0.61 | $-0.88 | $-1.35 | $-3.71 | $-1.79 | $-2.52 | $-0.17 | $-0.17 | $-0.17 | |
| EPS (Diluted) | · | $-0.21 | · | · | $-0.40 | $-0.59 | · | · | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 12,093,268 | 10,812,419 | · | 6,277,848 | 5,059,736 | 4,635,764 | · | 2,827,492 | 1,877,069 | 1,675,539 | · | 1,441,043 | 1,358,968 | 20,177,167 | · | 17,844,991 | |
| Shares (Diluted) | · | 10,812,419 | · | · | 5,059,736 | 4,635,764 | · | · | · | · | · | · | · | · | · | · | |
| EBITDA | $-2M | $-2M | · | $-1M | $-2M | $-3M | · | $-2M | $-2M | $-2M | · | $-3M | $-3M | $-3M | · | $-3M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $951.0K | $2M | $5M | $980.0K | $949.0K | $2M | $5M | $1M | $949.0K | $1M | $2M | $4M | $5M | $7M | $7M | |
| Receivables | $30.0K | $20.0K | $20.0K | · | $10.0K | · | $0 | $10.0K | $10.0K | $58.0K | $63.0K | $104.0K | $115.0K | $153.0K | $201.0K | $300.0K | |
| Prepaid Expense | $151.0K | $169.0K | $216.0K | $78.0K | $209.0K | $224.0K | $251.0K | $116.0K | $142.0K | $252.0K | $295.0K | $177.0K | $230.0K | $279.0K | $300.0K | $187.0K | |
| Current Assets | $4M | $1M | $3M | $5M | $1M | $1M | $3M | $5M | $2M | $1M | $1M | $2M | $5M | $5M | $8M | $7M | |
| PP&E (Net) | $13.0K | $16.0K | $16.0K | $13.0K | $17.0K | $21.0K | $33.0K | $47.0K | $61.0K | $75.0K | $94.0K | $114.0K | $139.0K | $158.0K | $170.0K | $189.0K | |
| PP&E (Gross) | $804.0K | $804.0K | $801.0K | $795.0K | $795.0K | $794.0K | $794.0K | $793.0K | $791.0K | $788.0K | $788.0K | $788.0K | $801.0K | $799.0K | $789.0K | $787.0K | |
| Accum. Depreciation | $791.0K | $788.0K | $785.0K | $782.0K | $778.0K | $773.0K | $761.0K | $746.0K | $730.0K | $713.0K | $694.0K | $674.0K | $662.0K | $641.0K | $619.0K | $598.0K | |
| Other Non-current Assets | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $172.0K | $171.0K | $172.0K | |
| Total Assets | $5M | $2M | $3M | $6M | $2M | $2M | $4M | $6M | $3M | $3M | $3M | $4M | $6M | $7M | $10M | $9M | |
| Accounts Payable | $541.0K | $820.0K | $641.0K | $1M | $1M | $818.0K | $385.0K | $569.0K | $1M | $1M | $890.0K | $507.0K | $686.0K | $861.0K | $683.0K | $887.0K | |
| Accrued Liabilities | $30.0K | $52.0K | $34.0K | $108.0K | $41.0K | $243.0K | $22.0K | $28.0K | $4.0K | $116.0K | $75.0K | $36.0K | $111.0K | $38.0K | $157.0K | $115.0K | |
| Current Liabilities | $2M | $3M | $2M | $3M | $4M | $3M | $2M | $3M | $4M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | |
| Capital Leases | $0 | $0 | $86.0K | $211.0K | $333.0K | $452.0K | $566.0K | $674.0K | $780.0K | $883.0K | $982.0K | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $2M | $3M | $3M | $4M | $4M | $4M | $3M | $4M | $5M | $5M | $5M | $4M | $5M | $5M | $5M | $5M | |
| Common Stock | $15.0K | $11.0K | $11.0K | $11.0K | $6.0K | $5.0K | $5.0K | $5.0K | $2.0K | $27.0K | $2.0K | $22.0K | $22.0K | $20.0K | $20.0K | $18.0K | |
| Paid-in Capital | $175M | $170M | $169M | $169M | $163M | $161M | $161M | $161M | $154M | $152M | $151M | $149M | $149M | $146M | $145M | $142M | |
| Retained Earnings | $-172M | $-171M | $-168M | $-166M | $-165M | $-163M | $-160M | $-158M | $-156M | $-154M | $-152M | $-150M | $-148M | $-144M | $-141M | $-138M | |
| Stockholders' Equity | $3M | $-1M | $895.0K | $3M | $-2M | $-2M | $837.0K | $3M | $-2M | $-2M | $-2M | $-660.0K | $2M | $2M | $5M | $4M | |
| Liabilities + Equity | $5M | $2M | $3M | $6M | $2M | $2M | $4M | $6M | $3M | $3M | $3M | $4M | $6M | $7M | $10M | $9M | |
| Shares Outstanding | 14,984,323 | 10,940,372 | 10,755,647 | 10,608,734 | 5,504,802 | 4,682,184 | 4,600,910 | 4,523,876 | 2,123,876 | 26,836,389 | · | 21,619,432 | 21,586,150 | 20,202,005 | · | 17,841,927 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.0K | $3.0K | $3.0K | $4.0K | $5.0K | $12.0K | $15.0K | $16.0K | $17.0K | $19.0K | $20.0K | $21.0K | $21.0K | $22.0K | $21.0K | $29.0K | |
| Stock-based Comp | $109.0K | $113.0K | $85.0K | $77.0K | $98.0K | $170.0K | $176.0K | $177.0K | $184.0K | $204.0K | $184.0K | $251.0K | $317.0K | $278.0K | $280.0K | $280.0K | |
| Other Non-cash | · | $484.0K | · | · | · | $912.0K | · | · | · | $514.0K | · | · | · | $641.0K | · | · | |
| Operating Cash Flow | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-1M | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M | $-2M | |
| CapEx | $0 | $3.0K | $6.0K | $0 | $1.0K | $0 | $1.0K | $2.0K | $3.0K | $0 | $0 | $0 | $2.0K | $10.0K | $2.0K | $14.0K | |
| Investing Cash Flow | $0 | $-3.0K | $-6.0K | $0 | $-1.0K | $0 | $-1.0K | $-2.0K | $-3.0K | $0 | $0 | $0 | $-2.0K | $-10.0K | $-2.0K | $-14.0K | |
| Stock Issued | $5M | $225.0K | $0 | $7M | $2M | $212.0K | $39.0K | $7M | $2M | $1M | $1M | $92.0K | $3M | $244.0K | $4M | $139.0K | |
| Net Stock Activity | · | $225.0K | · | · | · | $212.0K | · | · | · | $1M | · | · | · | $244.0K | · | · | |
| Financing Cash Flow | $5M | $117.0K | $-288.0K | $6M | $2M | $196.0K | $-125.0K | $6M | $2M | $1M | $1M | $-58.0K | $3M | $64.0K | $4M | $73.0K | |
| Net Change in Cash | $3M | $-2M | $-3M | $4M | $31.0K | $-1M | $-3M | $4M | $472.0K | $-154.0K | $-732.0K | $-2M | $-552.0K | $-3M | $696.0K | $-2M | |
| Free Cash Flow | · | $-2M | · | · | · | · | · | · | · | $-2M | · | · | · | $-3M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -54966.7% | -4136.4% | · | -727.7% | -8027.9% | -5484.4% | · | -1443.4% | |
| Net Margin | · | · | · | · | · | · | · | · | -54866.7% | -4121.8% | · | -721.0% | -7962.8% | -5470.3% | · | -1442.0% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -54966.7% | -4101.8% | · | -727.7% | -8027.9% | -5450.0% | · | -1443.4% | |
| ROA | -47.1% | -116.5% | · | -23.9% | -82.3% | -111.9% | · | -34.7% | -35.5% | -46.2% | · | -39.8% | -38.8% | -35.1% | · | -23.1% | |
| ROE | -396.3% | 174.7% | · | -55.1% | 106.5% | 142.9% | · | -166.0% | 1009.8% | 1209.1% | · | -149.8% | -81.8% | -75.5% | · | -34.9% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 0.4 | · | 1.6 | 0.3 | 0.4 | · | 1.8 | 0.4 | 0.3 | · | 0.6 | 1.3 | 1.3 | · | 1.9 | |
| Quick Ratio | 2.0 | 0.3 | · | 1.6 | 0.3 | 0.3 | · | 1.7 | 0.4 | 0.2 | · | 0.6 | 1.2 | 1.3 | · | 1.9 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | 0.0 | · | · | 0.0 | 0.0 | 0.5 | · | 1.8 | 0.3 | 0.3 | · | 0.9 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.18 | $-0.10 | · | $0.25 | $-0.34 | $-0.32 | · | $0.61 | $-0.92 | $-0.08 | · | $-0.03 | $0.08 | $0.09 | · | $0.23 | |
| Cash Flow / Share | · | $-0.15 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.27 | $0.09 | · | $0.50 | $0.18 | $0.20 | · | $1.09 | $0.67 | $0.04 | · | $0.08 | $0.20 | $0.24 | · | $0.37 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $3.0K | · | $71.0K | $428.0K | $468.0K | · | $570.0K | $425.0K | $1M | · | $1M | |
| Net Income TTM | $-7M | $-8M | · | $-9M | $-9M | $-8M | · | $-8M | $-9M | $-10M | · | $-13M | $-13M | $-12M | · | $-12M | |
| Market Cap | $19M | $13M | · | $14M | $11M | $12M | · | $14M | $6M | $165M | · | $139M | $865M | $591M | · | $519M | |
| P/S | · | · | · | · | · | 3964.2 | · | 198.8 | 14.7 | 352.7 | · | 244.6 | 2034.2 | 435.8 | · | 391.8 | |
| P/B | 6.9 | -12.4 | · | 5.2 | -5.7 | -7.8 | · | 5.1 | -3.2 | -72.5 | · | -211.3 | 528.8 | 311.0 | · | 126.7 | |
| P / Tangible Book | 6.9 | · | · | 5.2 | · | · | · | 5.1 | · | · | · | · | 528.8 | 311.0 | · | 126.7 | |
| P / Cash Flow | · | -8.0 | · | · | · | -7.4 | · | · | · | -107.9 | · | · | · | -230.8 | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $0 | $58.0K | $477.0K | $1M | $1M |
| Margen Operativo % | · | -13794.8% | -2441.1% | · | -1244.3% |
| Beneficio neto | $-8M | $-8M | $-12M | $-12M | $-13M |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 1.1 | 1.1 | 0.4 | · | 3.6 |
| Ratio Rápido | 1.0 | 1.0 | 0.3 | · | 3.5 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-7M | $-8M | $-10M | · | $-10M |
Propietarios institucionales (13F) 21 declarantes · $1.8M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
21
Valor en tenencia
$1.8M
Nuevas posiciones
6
Posiciones cerradas
5
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 6 (0 vs trimestre anterior) | 5 (+1 vs trimestre anterior) | 4 (-1 vs trimestre anterior) | 3 (+1 vs trimestre anterior) | +645K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| CITIGROUP INC | $493 017 | 397 594 | 27,40% | Acciones |
| CM Management, LLC | $372 000 | 300 000 | 20,68% | Acciones |
| VANGUARD GROUP INC | $169 452 | 135 561 | 9,42% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $154 493 | 124 591 | 8,59% | Acciones |
| Pingora Partners LLC | $149 274 | 120 382 | 8,30% | Acciones |
| UBS Group AG | $96 248 | 77 619 | 5,35% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $82 662 | 66 664 | 4,59% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $82 175 | 66 270 | 4,57% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48 123 | 38 809 | 2,67% | Acciones |
| BROWN ADVISORY INC | $44 067 | 35 538 | 2,45% | Acciones |
| COMMONWEALTH EQUITY SERVICES, LLC | $28 990 | 23 383 | 1,61% | Acciones |
| CITADEL ADVISORS LLC | $28 465 | 22 956 | 1,58% | Acciones |
| StoneX Group Inc. | $24 825 | 20 020 | 1,38% | Acciones |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $16 924 | 18 500 | 0,94% | Acciones |
| Tower Research Capital LLC (TRC) | $3 952 | 3 187 | 0,22% | Acciones |
| MORGAN STANLEY | $3 850 | 3 105 | 0,21% | Acciones |
| Global Retirement Partners, LLC | $510 | 411 | 0,03% | Acciones |
| GSA CAPITAL PARTNERS LLP | $16 | 12 862 | 0,00% | Acciones |
| SBI Securities Co., Ltd. | $11 | 9 | 0,00% | Acciones |
| OSAIC HOLDINGS, INC. | $1 | 1 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 26 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Blank Andrew Scott | 22 de mayo de 2025 | 5,50% | Presentación inicial | Campaña de la junta directiva | SEC |
| Daly Joseph Patrick | 21 de mayo de 2025 | 0,00% | Enmienda | · | SEC |
| Phillip Frost, M.D., Frost Gamma Investments Trust ×13 presentaciones | 5 de abril de 2024 | · | Presentación inicial | · | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 25 de mayo de 2023 | · | Presentación inicial | Inversión pasiva | SEC |
| Jim L. Allen ×2 presentaciones | 9 de enero de 2023 | · | Presentación inicial | Inversión pasiva | SEC |
| Simon H. Stertzer (2), Kimberly Stertzer (2), Stertzer Family Trust (2), Windrock Enterprises L.L.C. (2) ×4 presentaciones | 9 de enero de 2023 | · | Presentación inicial | · | SEC |
| Roumell Asset Management, LLC ("RAM"), James C. Roumell (Roumell) ×2 presentaciones | 7 de febrero de 2022 | · | Presentación inicial | Inversión pasiva | SEC |
| OPKO Health, Inc. ×2 presentaciones | 23 de octubre de 2019 | · | Presentación inicial | · | SEC |
| Andrew A. Brooks, M.D. ×4 presentaciones | 19 de mayo de 2016 | · | Presentación inicial | · | SEC |
| Jonathan Brooks ×3 presentaciones | 18 de mayo de 2016 | · | Presentación inicial | · | SEC |
| Mikhail Kvitnitsky ×2 presentaciones | 5 de julio de 2011 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 24 de marzo de 2008 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 24 de marzo de 2008 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 19 de marzo de 2008 | · | Presentación inicial | · | SEC |
| Persona informante no revelada, Persona informante no revelada | 19 de marzo de 2008 | · | Presentación inicial | · | SEC |
| Dr. Jane Hsiao, Ph. D. | 18 de marzo de 2008 | · | Presentación inicial | Inversión pasiva | SEC |
| Glenn L. Halpryn | 15 de enero de 2008 | · | Presentación inicial | Inversión pasiva | SEC |
| Steven Jerry Glauser, Steven Jerry Glauser Revocable Trust IRS ID | 15 de enero de 2008 | · | Presentación inicial | Inversión pasiva | SEC |
| Stephen Bittel | 15 de enero de 2008 | · | Presentación inicial | Inversión pasiva | SEC |
| Ernest M. Halpryn | 15 de enero de 2008 | · | Presentación inicial | Inversión pasiva | SEC |
| Roy Israel S.S. or, Carla Israel S.S. or | 28 de septiembre de 2007 | · | Presentación inicial | · | SEC |
| Persona informante no revelada, Persona informante no revelada | 15 de abril de 2005 | · | Presentación inicial | · | SEC |
| Persona informante no revelada, Persona informante no revelada | 18 de enero de 2005 | · | Presentación inicial | · | SEC |
| Persona informante no revelada, Persona informante no revelada | 12 de marzo de 2004 | · | Presentación inicial | · | SEC |
| Persona informante no revelada, Persona informante no revelada | 17 de marzo de 2003 | · | Presentación inicial | · | SEC |
| Persona informante no revelada, Persona informante no revelada | 20 de noviembre de 2001 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 38 insiders · 10 directivos · 22 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Peter Altman | President and CEO | 29 de septiembre de 2026 P | 384 885 | 30 | 0 | $65 582 |
| Steven D Rubin | Interim CEO and Interim CFO | 11 de agosto de 2016 A | 302 822 | 0 | 0 | $0 |
| Andrew A Brooks | CEO | 10 de mayo de 2016 S | 0 | 0 | 0 | $0 |
| Glenn L Halpryn | CEO | 29 de agosto de 2008 J | 533 312 | 0 | 0 | $0 |
| Roy Israel | Chairman,CEO & President | 26 de septiembre de 2007 S | 0 | 0 | 0 | $0 |
| David Mcclung | Chief Financial Officer | 6 de julio de 2026 A | 114 245 | 0 | 0 | $0 |
| Edward M Gillis | Senior Vice President, Devices | 6 de julio de 2026 A | 54 126 | 0 | 0 | $0 |
| Eric Duckers | Chief Medical Officer | 2 de noviembre de 2020 S | 12 088 | 0 | 0 | $0 |
| Phil Pesta | Vice President of Operations | 30 de junio de 2020 F | 11 867 | 0 | 0 | $0 |
| Richard T Allen | Vice President of Quality | 1 de febrero de 2018 A | 807 591 | 0 | 0 | $0 |
| Bill Facteau | Consejero | 6 de julio de 2026 A | 13 123 | 0 | 0 | $0 |
| Marvin Slosman | Consejero | 6 de julio de 2026 A | · | 0 | 0 | $0 |
| Blank Andrew Scott | Consejero | 6 de julio de 2026 A | 634 023 | 0 | 0 | $0 |
| Jim L. Allen | Consejero | 6 de julio de 2026 A | 109 661 | 0 | 0 | $0 |
| Jay M Moyes | Consejero | 6 de julio de 2026 A | 54 267 | 0 | 0 | $0 |
| STERTZER SIMON H | Consejero | 6 de julio de 2026 A | 166 338 | 2 | 0 | $103 584 |
| Richard M Krasno | Consejero | 23 de abril de 2025 P | 16 268 | 0 | 0 | $0 |
| Krisztina M Zsebo | Consejero | 14 de abril de 2022 A | 2 980 | 0 | 0 | $0 |
| Richard C Pfenniger JR | Consejero | 31 de diciembre de 2020 A | 51 970 | 0 | 0 | $0 |
| Fernando L Fernandez | Consejero | 30 de septiembre de 2020 A | 40 644 | 0 | 0 | $0 |
| Thomas Quertermous | Consejero | 26 de julio de 2019 M | 15 681 | 0 | 0 | $0 |
| TESSLER ALLAN R | Consejero | 26 de julio de 2019 M | 23 186 | 0 | 0 | $0 |
| Stephen H Liu | Consejero | 11 de agosto de 2016 A | 75 000 | 0 | 0 | $0 |
| Subbarao V Uppaluri | Consejero | 11 de agosto de 2016 A | 471 592 | 0 | 0 | $0 |
| Ronald N. Richards | Consejero | 10 de mayo de 2016 S | 0 | 0 | 0 | $0 |
| Thomas H. Morgan | Consejero | 10 de mayo de 2016 S | 40 419 | 0 | 0 | $0 |
| Jonathan Brooks | Consejero | 10 de mayo de 2016 S | 91 000 | 0 | 0 | $0 |
| Mikhail Kvitnitsky | Propietario del 10% | 1 de julio de 2011 S | 0 | 0 | 0 | $0 |
| Steven Jerry Glauser | · | 29 de agosto de 2008 J | 7 865 768 | 0 | 0 | $0 |
| Kenneth W Good | · | 26 de septiembre de 2007 S | 0 | 0 | 0 | $0 |
| Willem F Specht | · | 26 de septiembre de 2007 S | 0 | 0 | 0 | $0 |
| Rheaume Patricia A Giuliani | · | 26 de septiembre de 2007 S | 0 | 0 | 0 | $0 |
| Robert M Silverson JR | · | 30 de junio de 2004 A | · | 0 | 0 | $0 |
| Anthony J Mercorella | · | 30 de junio de 2004 A | · | 0 | 0 | $0 |
| Correy J Gottlieb | · | 30 de junio de 2004 A | · | 0 | 0 | $0 |
| Randy Gerstenblatt | · | 30 de junio de 2004 A | · | 0 | 0 | $0 |
| Kenneth G Geraghty | · | 30 de junio de 2004 A | · | 0 | 0 | $0 |
| Alan Littman | · | 4 de junio de 2004 A | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 2 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
BCDA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 8 analistas
COMPRA
Objetivo mediano
$15.50
+1390,4%
2 25,0%
Compra fuerte
5 62,5%
Compra
1 12,5%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
2 analistas · 2026-09-30Objetivo medio $15.50 +1390,4%
← Por Debajo de Todos los Objetivos
Precio Actual $1.04
Mín$6.00
Media$15.50
Máx$25.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 12, 2026